Medicines For Europe Proposes Revised Remodulation To EU Exclusivity Proposals

Trade Group Believes Market Exclusivity Should Face Incentive Extensions, Not Data Exclusivity

Sergio Napolitano speaking at Medicines for Europe's 22nd Regulatory Affairs and Pharmacovigilance Conference
Napolitano explained Medicines for Europe's proposals at its 22nd Regulatory Affairs and Pharmacovigilance Conference • Source: Medicines for Europe

More from Policy & Regulation

More from Generics Bulletin